Bactiguard Holding Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Christine Lind

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	less than a year
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	1.2yrs
Gemiddelde ambtstermijn bestuur	5.5yrs

Recente managementupdates

Recent updates

Bactiguard Holding AB (publ) (STO:BACTI B) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely

Oct 08

Bactiguard Holding (STO:BACTI B) Is Making Moderate Use Of Debt

Sep 03

Bactiguard Holding AB (publ)'s (STO:BACTI B) 30% Share Price Surge Not Quite Adding Up

Feb 06

Bactiguard Holding (STO:BACTI B) Is Carrying A Fair Bit Of Debt

Jan 12

Is Bactiguard Holding (STO:BACTI B) Using Debt In A Risky Way?

Jul 02

Bactiguard Holding AB (publ)'s (STO:BACTI B) Business Is Trailing The Industry But Its Shares Aren't

May 05

CEO

Christine Lind (50 yo)

less than a year

Tenure

Ms. Christine Lind serves as Chief Executive Officer of Bactiguard Holding AB (publ) since April 12, 2024. She served as Independent Director at Mendus AB (publ) (formerly known as Immunicum AB (publ)) fro...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Christine Lind	Chief Executive Officer	less than a year	geen gegevens	geen gegevens
Patrick Bach	Chief Financial Officer	less than a year	geen gegevens	geen gegevens
Mikael Sander	Chief Operating Officer	1.8yrs	geen gegevens	geen gegevens
Nina Nornholm	Head of Corporate Communication & Investor Relations	1.3yrs	geen gegevens	geen gegevens
Nathaniel Bachrach	Interim Head of R&D	no data	geen gegevens	geen gegevens

1.2yrs

Gemiddelde duur

53.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van BACTI B wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.2 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Jan Stahlberg	Independent Director	6.5yrs	SEK 400.00k	10.29% SEK 146.0m
Thomas von Koch	Chairman of the Board	5.5yrs	SEK 250.00k	18.39% SEK 261.0m
Richard Kuntz	Independent Director	1.5yrs	SEK 300.00k	geen gegevens
Kenneth Chien	Chairman of the Scientific Advisory Board	10.8yrs	geen gegevens	geen gegevens
Magdalena Persson	Independent Director	2.6yrs	SEK 400.00k	geen gegevens
Kwong-Hang Tam	Member of the Scientific Advisory Board	no data	geen gegevens	geen gegevens
Staffan Holmin	Member of the Scientific Advisory Board	no data	geen gegevens	geen gegevens
David Finn	Member of the Scientific Advisory Board	no data	geen gegevens	geen gegevens
Anna Martling	Independent Director	5.5yrs	SEK 400.00k	0.0098% SEK 138.7k

5.5yrs

Gemiddelde duur

58yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van BACTI B wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.5 jaar).

Bactiguard Holding Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Director recently bought kr129m worth of stock

Bactiguard Holding Ab Appoints Thomas Von Koch as the Chairman of the Board of Directors

Director recently bought kr6.8m worth of stock

Bactiguard Holding AB (publ.) Announces CEO Changes as of 12 April 2024

Christian Kinch Declines Re-Election as Board Member of Bactiguard Holding AB (publ)

Interim CEO & Director recently bought kr13m worth of stock

Recent updates

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Bactiguard Holding AB (publ) to Report Q3, 2025 Results on Oct 23, 2025

Bactiguard Holding AB (publ) (STO:BACTI B) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely

Bactiguard Holding (STO:BACTI B) Is Making Moderate Use Of Debt

New minor risk - Insider selling

Consensus estimates of losses per share improve by 14%

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

No longer forecast to breakeven

Forecast to breakeven in 2026

Director recently bought kr129m worth of stock

Bactiguard Holding Ab Appoints Thomas Von Koch as the Chairman of the Board of Directors

Forecast to breakeven in 2026

Director recently bought kr6.8m worth of stock

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Forecast to breakeven in 2026

Bactiguard Holding AB (publ.) Announces CEO Changes as of 12 April 2024

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Christian Kinch Declines Re-Election as Board Member of Bactiguard Holding AB (publ)

Interim CEO & Director recently bought kr13m worth of stock

New minor risk - Share price stability

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Bactiguard Announces CEO Changes

Bactiguard Holding AB (publ)'s (STO:BACTI B) 30% Share Price Surge Not Quite Adding Up

Bactiguard Holding (STO:BACTI B) Is Carrying A Fair Bit Of Debt

Bactiguard Holding AB (Publ) Announces Executive Changes

Interim CEO & Director recently bought kr9.1m worth of stock

Bactiguard Holding AB (publ), Annual General Meeting, May 14, 2024

Third quarter 2023 earnings released

Bactiguard Holding AB (publ) to Report Q1, 2024 Results on Apr 25, 2024

Bactiguard Announces Publishing of New Study

Second quarter 2023 earnings released

Is Bactiguard Holding (STO:BACTI B) Using Debt In A Risky Way?

New minor risk - Share price stability

Bactiguard Holding AB (Publ) Announces CEO Changes

Bactiguard Holding AB (Publ) Elects Rick Kuntz as Member of the Board

Independent Chairman of the Board recently bought kr24m worth of stock

Bactiguard Holding AB (publ)'s (STO:BACTI B) Business Is Trailing The Industry But Its Shares Aren't

Full year 2022 earnings released: kr1.51 loss per share (vs kr1.68 loss in FY 2021)

Bactiguard Holding (STO:BACTI B) Has Debt But No Earnings; Should You Worry?

Full year 2022 earnings released: kr1.51 loss per share (vs kr1.68 loss in FY 2021)

Bactiguard Holding AB (publ) to Report Fiscal Year 2022 Results on Feb 09, 2023

Bactiguard Holding AB (Publ) Receives First MDR Product Approval

Bactiguard Holding AB (publ) Announces Nomination Committee Appointments

Third quarter 2022 earnings released

Bactiguard Holding AB (publ) to Report Fiscal Year 2022 Results on Apr 05, 2023

Does Bactiguard Holding (STO:BACTI B) Have A Healthy Balance Sheet?

Second quarter 2022 earnings released

Bactiguard Announces European Patent Office Intends to Grant A European Patent for Bactiguard's Infection Prevention Technology

Independent Director recently bought kr2.7m worth of stock

Independent Director recently bought kr6.1m worth of stock

Is Bactiguard Holding (STO:BACTI B) Using Debt Sensibly?

Bactiguard Holding AB (publ) Elects Magdalena Persson as New Member of the Board

First quarter 2022 earnings: Revenues in line with analyst expectations

Full year 2021 earnings: EPS misses analyst expectations

Full year 2021 earnings: EPS exceeds analyst expectations

Does Bactiguard Holding (STO:BACTI B) Have A Healthy Balance Sheet?

Third quarter 2021 earnings released

First quarter 2021 earnings released: kr0.31 loss per share (vs kr0.34 loss in 1Q 2020)

Full year 2020 earnings released: kr1.14 loss per share (vs kr0.49 profit in FY 2019)

New 90-day high: kr162

Is Bactiguard Holding (STO:BACTI B) Using Too Much Debt?

Bactiguard Holding AB (publ) Announces Health Canada Provides COVID-19 Interim Order Approval for Bactiguard's Tempsensor Catheter

Full year 2020 earnings released

New 90-day high: kr160

Bactiguard Holding AB (publ) Announces Resignation of Cecilia Edström as Chief Executive Officer

Bactiguard Holding AB (publ) to Report Fiscal Year 2020 Results on Feb 04, 2021

Bactiguard Recruits Peter Rådqvist as Global Head of Sales, Effective 1 February 2021

Do Institutions Own Bactiguard Holding AB (publ) (STO:BACTI B) Shares?

Bactiguard Enters into A New Partnership with Lifecyn S.A. in Greece